One possible explanation is that, under normal conditions, p53 signaling dominant in PiHL regulation in p53 wildtype CRC cells, while in p53 mutant cells, HMGA2 plays a superior role in PiHL signaling. The gene discussed is HMGA2; the disease is colorectal carcinoma.